Home >> Chemicals Listing >> hot product list by 5  

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2R)-2-(formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,sodium salt (1:1), (6R,7R)- (42540-40-9)

Identification
Name:5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2R)-2-(formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,sodium salt (1:1), (6R,7R)-
Synonyms:5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2R)-(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt, (6R,7R)- (9CI);5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt, [6R-[6a,7b(R*)]]-; Bergacef; Cedol; Cefam;Cefamandole formate sodium; Cefamandole nafate; Cefiran; Cemado; Cemandil;Cephamandole nafate; Fado; Kefadol; Kefandol; Lampomandol; Mandokef; Mandol;Mandolsan; NSC 299588; Neocefal; O-Formylcefamandole sodium; Pavecef; Sodium7-(D-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1H-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylate;Sodium O-formylcefamandole
CAS:42540-40-9
EINECS: 255-877-4
Molecular Formula: C19H18 N6 O6 S2 . Na
Molecular Weight: 513.54
InChI: InChI=1/C19H18N6O6S2.Na/c1-24-19(21-22-23-24)33-8-11-7-32-17-12(16(28)25(17)13(11)18(29)30)20-15(27)14(31-9-26)10-5-3-2-4-6-10;/h2-6,9,12,14,17H,7-8H2,1H3,(H,20,27)(H,29,30);/q;+1/p-1/t12-,14-,17-;/m1./s1
Molecular Structure: (C19H18N6O6S2.Na) 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2R)-(formyloxy)phenylacetyl]amino]-3-[[(1-...
Properties
Appearance:White solid
Specification:

The Cefamandole nafate ,?with cas registry number of 42540-40-9, is a kind of Anti-Bacterial Agents; Anti-Infective Agents; Antibacterial; and Drug / Therapeutic Agent. Its IUPAC name is called sodium (6R,7R)-7-[[(2R)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate . And its systematic name is Sodium (6R-(6alpha,7beta(R*)))-7-(((formyloxy)phenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate .

Physical properties of?Cefamandole nafate are:?(1) ACD/LogP: 1.80 ; (2) # of Rule of 5 Violations: 1 ; (3) #H bond acceptors: 12 ; (4) #H bond donors: 2 ; (5) #Freely Rotating Bonds: 9 ; (6) Polar Surface Area: 198.42??2.

When you are using this chemical, please be cautious about it as the following:
The Cefamandole nafate is moderately toxic by intravenous route. It is irritating to eyes, respiratory system and skin, and may cause sensitization by inhalation and skin contact. When heated to decomposition, it emits very toxic fumes of NOx, Na2O and SOx. Wear suitable protective clothing before use it. If contact with eyes, rinse immediately with plenty of water and seek medical advice.

You can still convert the following datas into molecular structure:
(1)InChI:InChI=1/C19H18N6O6S2.Na/c1-24-19(21-22-23-24)33-8-11-7-32-17-12(16(28)25(17)13(11)18(29)30)20-15(27)14(31-9-26)10-5-3-2-4-6-10;/h2-6,9,12,14,17H,7-8H2,1H3,(H,20,27)(H,29,30);/q;+1/p-1/t12-,14+,17-;/m1./s1 ;
(2)Smiles:N12[C@@H]([C@@H](NC([C@H](c3ccccc3)OC=O)=O)C2=O)SCC(=C1C(=O)[O-])CSc1n(nnn1)C.[Na+]

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD intravenous > 1gm/kg (1000mg/kg) ? Journal of Infectious Diseases. Vol. 137, Pg. S51, 1978.
dog LD intravenous > 1gm/kg (1000mg/kg) ? Journal of Infectious Diseases. Vol. 137, Pg. S51, 1978.
man TDLo intravenous 400ug/kg/1W-I (0.4mg/kg) LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED" Drug Intelligence and Clinical Pharmacy. Vol. 19, Pg. 553, 1985.
man TDLo unreported 771mg/kg/9D-I (771mg/kg) BLOOD: CHANGE IN CLOTTING FACTORS Archives of Internal Medicine. Vol. 146, Pg. 1125, 1986.
mouse LD50 intravenous 3915mg/kg (3915mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Journal of Infectious Diseases. Vol. 137, Pg. S51, 1978.
mouse LD50 subcutaneous 7gm/kg (7000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Journal of Infectious Diseases. Vol. 137, Pg. S51, 1978.
rabbit LD50 intravenous > 2gm/kg (2000mg/kg) ? Journal of Infectious Diseases. Vol. 137, Pg. S51, 1978.
rat LD subcutaneous > 5gm/kg (5000mg/kg) ? Journal of Infectious Diseases. Vol. 137, Pg. S51, 1978.
rat LD50 intravenous 2562mg/kg (2562mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Journal of Infectious Diseases. Vol. 137, Pg. S51, 1978.
women TDLo intravenous 240mg/kg/2D-I (240mg/kg) MUSCULOSKELETAL: JOINTS Southern Medical Journal. Vol. 78, Pg. 1268, 1985.
women TDLo unreported 408mg/kg/4D-I (408mg/kg) BLOOD: CHANGE IN CLOTTING FACTORS Archives of Internal Medicine. Vol. 146, Pg. 1125, 1986.

Storage Temperature: -20?C Freezer, Under Inert Atmosphere
Safety Data
 

Other Product